We are live on ! Find out more
SGC

Slocum, Gordon & Co Portfolio holdings

AUM $151M
1-Year Est. Return 26.83%
This Fund
S&P 500
This Quarter Est. Return
-3.56%
1 Year Est. Return
+26.83%
3 Year Est. Return
+55.15%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$121M
AUM Growth
-$34.6M
Cap. Flow
-$27.9M
Cap. Flow %
-23.11%
Top 10 Hldgs %
61.52%
Holding
148
New
5
Increased
6
Reduced
31
Closed
4

Top Buys

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$318K
2
GEHC icon
GE HealthCare
GEHC
+$273K
3
ETN icon
Eaton
ETN
+$211K
4
MCD icon
McDonald's
MCD
+$134K
5
GLD icon
SPDR Gold Trust
GLD
+$99.6K

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$2.5M
2
VST icon
Vistra
VST
+$2.34M
3
ABBV icon
AbbVie
ABBV
+$1.96M
4
PG icon
Procter & Gamble
PG
+$1.89M
5
OXY icon
Occidental Petroleum
OXY
+$1.88M

Sector Composition

Rank Sector Weight
1 Healthcare 32.37%
2 Utilities 24.61%
3 Consumer Staples 13.21%
4 Energy 9.65%
5 Communication Services 6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNP icon
26
Union Pacific
UNP
$172B
$907K 0.75%
4,509
– –
DD icon
27
DuPont de Nemours
DD
$18.7B
$855K 0.71%
9,495
-1,673
-15% -$153K
DOW icon
28
Dow Inc
DOW
$21.7B
$704K 0.58%
12,842
-2,500
-16% -$141K
GIS icon
29
General Mills
GIS
$19.4B
$615K 0.51%
7,200
– –
CAT icon
30
Caterpillar
CAT
$373B
$572K 0.47%
2,500
– –
HD icon
31
Home Depot
HD
$332B
$545K 0.45%
1,848
– –
WMT icon
32
Walmart Inc
WMT
$884B
$530K 0.44%
10,785
– –
VOD icon
33
Vodafone
VOD
$37.2B
$481K 0.4%
43,557
-21,000
-33% -$239K
ABT icon
34
Abbott
ABT
$183B
$476K 0.39%
4,700
-1
-0% -$106
PEP icon
35
PepsiCo
PEP
$191B
$433K 0.36%
2,376
– –
RVTY icon
36
Revvity
RVTY
$12.7B
$393K 0.33%
2,950
– –
TMO icon
37
Thermo Fisher Scientific
TMO
$214B
$383K 0.32%
664
– –
CL icon
38
Colgate-Palmolive
CL
$73.3B
$334K 0.28%
4,446
– –
BRK.B icon
39
Berkshire Hathaway Class B
BRK.B
$1.1T
$333K 0.28%
1,078
– –
ZTS icon
40
Zoetis
ZTS
$31.9B
$323K 0.27%
+1,942
New +$318K
GEHC icon
41
GE HealthCare
GEHC
$31.6B
$314K 0.26%
+3,824
New +$273K
BAX icon
42
Baxter International
BAX
$13.8B
$270K 0.22%
6,655
-20,300
-75% -$861K
AMGN icon
43
Amgen
AMGN
$209B
$257K 0.21%
1,062
– –
BMY icon
44
Bristol-Myers Squibb
BMY
$132B
$243K 0.2%
3,504
+1,257
+56% +$88.7K
BRKL
45
DELISTED
Brookline Bancorp
BRKL
$242K 0.2%
23,087
– –
CVX icon
46
Chevron
CVX
$383B
$220K 0.18%
1,347
– –
ETN icon
47
Eaton
ETN
$150B
$217K 0.18%
+1,265
New +$211K
TRV icon
48
Travelers Companies
TRV
$78.4B
$214K 0.18%
1,250
– –
NSC icon
49
Norfolk Southern
NSC
$75B
$208K 0.17%
982
– –
IVV icon
50
iShares Core S&P 500 ETF
IVV
$872B
$195K 0.16%
474
– –
1
2
3 4 5

Similar funds

LM
Lansing Management New York $151M AUM 13.85% 1-Year Est. Return
CAM
Crown Advisors Management Larkspur, California $151M AUM 73.11% 1-Year Est. Return
FC
FACT Capital New York $150M AUM 53.4% 1-Year Est. Return
JIM
JCP Investment Management Houston, Texas $150M AUM 19.22% 1-Year Est. Return
WBCM
Wilson & Boucher Capital Management Moraga, California $151M AUM 18.75% 1-Year Est. Return
BDS
Banco de Sabadell Miami, Florida $151M AUM 22.94% 1-Year Est. Return
CCM
Crew Capital Management Cincinnati, Ohio $151M AUM 20.49% 1-Year Est. Return
SHF
Stage Harbor Financial Westwood, Massachusetts $151M AUM 15.9% 1-Year Est. Return

Slocum, Gordon & Co's Q1 2023 Portfolio in Review

As of Q1 2023, Slocum, Gordon & Co held 148 positions worth $121M, down 22% from $155M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Slocum, Gordon & Co withdrew a net $27.9M in Q1 2023, closing 4 positions and reducing 31 holdings. Its most notable exit was Apple, an estimated $1.28M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Utilities and Consumer Staples.

Against the trend, Slocum, Gordon & Co opened a new position in Zoetis worth $323K.

  • Slocum, Gordon & Co's largest Q1 2023 buy was Zoetis: 1,942 shares worth $323K.
  • Slocum, Gordon & Co added most to McDonald's in Q1 2023, an estimated $134K increase.
  • Slocum, Gordon & Co's biggest Q1 2023 reduction was Merck, cutting an estimated $2.5M.
  • Slocum, Gordon & Co fully exited Apple in Q1 2023, selling an estimated $1.28M.
  • Slocum, Gordon & Co's ten largest holdings make up 62% of its $121M portfolio in Q1 2023.
  • Slocum, Gordon & Co opened 5 new positions and closed 4 in Q1 2023.
  • Slocum, Gordon & Co's portfolio value fell 22% quarter-over-quarter to $121M.

Based on Slocum, Gordon & Co's 13F filing for Q1 2023, filed 14 Dec 2023.